Vitalhub Corp. (TSE:VHI - Free Report) - Raymond James Financial dropped their Q1 2026 earnings per share (EPS) estimates for shares of Vitalhub in a research report issued to clients and investors on Monday, August 11th. Raymond James Financial analyst M. Freeman now anticipates that the company will post earnings of $0.06 per share for the quarter, down from their previous forecast of $0.07. Raymond James Financial currently has a "Outperform" rating and a $15.00 target price on the stock. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. Raymond James Financial also issued estimates for Vitalhub's Q2 2026 earnings at $0.08 EPS, Q4 2026 earnings at $0.09 EPS and FY2026 earnings at $0.31 EPS.
A number of other research analysts have also issued reports on the company. National Bankshares set a C$14.00 price target on Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. National Bank Financial raised Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th. TD Securities boosted their price objective on Vitalhub from C$15.00 to C$16.00 and gave the stock a "buy" rating in a research note on Monday. Finally, Scotiabank boosted their price objective on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research note on Friday, June 20th. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and a consensus price target of C$13.75.
Read Our Latest Analysis on VHI
Vitalhub Stock Up 4.7%
VHI stock opened at C$13.51 on Wednesday. Vitalhub has a 52-week low of C$7.62 and a 52-week high of C$14.64. The stock's 50 day moving average is C$11.97 and its two-hundred day moving average is C$10.89. The company has a market capitalization of C$730.79 million, a PE ratio of 219.74, a P/E/G ratio of 1.18 and a beta of 1.26.
Insider Buying and Selling
In other news, Director Francis Nelson Shen purchased 25,000 shares of the company's stock in a transaction on Friday, May 16th. The shares were purchased at an average price of C$10.23 per share, with a total value of C$255,750.00. Insiders own 18.57% of the company's stock.
Vitalhub Company Profile
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access